Cho Pharma Stock Net Asset
| 6586 Stock | TWD 50.90 0.50 0.97% |
CHO Pharma fundamentals help investors to digest information that contributes to CHO Pharma's financial success or failures. It also enables traders to predict the movement of CHO Stock. The fundamental analysis module provides a way to measure CHO Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CHO Pharma stock.
CHO |
CHO Pharma Company Net Asset Analysis
CHO Pharma's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Based on the recorded statements, CHO Pharma has a Net Asset of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Net Asset (which currently averages 0.0) industry. This indicator is about the same for all Taiwan stocks average (which is currently at 0.0).
CHO Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CHO Pharma's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CHO Pharma could also be used in its relative valuation, which is a method of valuing CHO Pharma by comparing valuation metrics of similar companies.CHO Pharma is currently under evaluation in net asset category among its peers.
CHO Fundamentals
About CHO Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CHO Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CHO Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CHO Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with CHO Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CHO Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHO Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against CHO Stock
| 0.56 | 2317 | Hon Hai Precision | PairCorr |
| 0.55 | 2882B | Cathay Financial Holding | PairCorr |
| 0.55 | 2881A | Fubon Financial Holding | PairCorr |
| 0.54 | 2454 | MediaTek | PairCorr |
| 0.48 | 0057 | Fubon MSCI Taiwan | PairCorr |
The ability to find closely correlated positions to CHO Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CHO Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CHO Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CHO Pharma to buy it.
The correlation of CHO Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CHO Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CHO Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CHO Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for CHO Stock Analysis
When running CHO Pharma's price analysis, check to measure CHO Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CHO Pharma is operating at the current time. Most of CHO Pharma's value examination focuses on studying past and present price action to predict the probability of CHO Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CHO Pharma's price. Additionally, you may evaluate how the addition of CHO Pharma to your portfolios can decrease your overall portfolio volatility.